Lung Cancer Considered in Turkish: First-Line Therapies in EGFR Mutant NSCLC

15/03/2025 56 min
Lung Cancer Considered in Turkish: First-Line Therapies in EGFR Mutant NSCLC

Listen "Lung Cancer Considered in Turkish: First-Line Therapies in EGFR Mutant NSCLC"

Episode Synopsis

Host: Ece Cali Daylan, Assistant Professor of Medicine, Division of Oncology at Washington University School of Medicine

Guest: Saadettin Kilickap
Guest: Ozden Altundag